Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Hepatocellular × Methods × 90 days × Clear all

Sponsor

Conditions

Colorectal Neoplasms 8 Breast Neoplasms 6 Lung Neoplasms 5 Triple Negative Breast Neoplasms 3 Prostatic Neoplasms 3 Papillomavirus Infections 3 Neoplasms 3 Neoplasm Metastasis 3 Lymphoma 3 Uterine Cervical Neoplasms 2 Smoking Cessation 2 Skin Carcinoma 2 Pain 2 Obesity-Related Malignant Neoplasm 2 Hematologic Neoplasms 2 Breast Carcinoma In Situ 2 Anatomic Stage I Breast Cancer AJCC v8 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Uveal Melanoma 1 Urinary Bladder Neoplasms 1 Tobacco Smoking 1 Smoking 1 Sepsis 1 Sarcoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pancreatic Cancer Liver Metastases 1 Ovarian Neoplasms 1 Leukemia, Myeloid, Acute 1 Inflammatory Breast Neoplasms 1

Interventions

Bevacizumab 24 atezolizumab 19 durvalumab 18 Specimen Handling 15 pembrolizumab 12 lenvatinib 11 Magnetic Resonance Spectroscopy 11 tremelimumab 10 Nivolumab 10 Sorafenib 8 Radiosurgery 8 Cyclophosphamide 6 camrelizumab 5 apatinib 5 Ipilimumab 5 tislelizumab 4 regorafenib 4 fludarabine 4 cabozantinib 4 X-Rays 4 Immunoglobulin G 4 sintilimab 3 gadolinium ethoxybenzyl DTPA 3 Immune Checkpoint Inhibitors 3 Ethiodized Oil 3 E-7386 3 Disulfides 3 Blood Specimen Collection 3 Biopsy 3 gadobutrol 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡